Public Company News

NYSE Content Advisory: Pre-market update + Wall Street anticipates Fed's next move

NEW YORK, July 29, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + Wall Street anticipat...

2025-07-29 20:57 2933

Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress

PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with moderate-to-severe atopic dermatitis (AD), wi...

2025-07-29 20:00 2576

CNOOC Limited Brings On-stream Dongfang 1-1 Gas Field 13-3 Block Development Project

HONG KONG, July 29, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that Dongfang 1-1 Gas Field 13-3 Block Development Project has commenced production. The project is the first high-temperature, high-pressure, l...

2025-07-29 16:30 2616

Companies Struggle to Meet Rising Demand for Personalized Benefits, Aon Survey Finds

Global survey of benefits professionals found only 14 percent of multinationals have global guidelines in place to support personalization DUBLIN, July 29, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today released its2025 Global Benefits Trends Study , ...

2025-07-29 16:00 3266

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

* Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. * Finished building will be one of the world's largest modular biologics Drug Product (DP) facilities, and will enhance W...

2025-07-29 16:00 4300

Macau's Oriental Pearl district property market poised for growth, fuelled by LRT East Line

The only private housing area directly adjacent to an LRT station, offering seamless connectivity acrossHong Kong, Zhuhai and Macau HONG KONG, July 29, 2025 /PRNewswire/ -- With phased construction of the East Line ofMacau's Light Rapid Transit (LRT) system commencing this month and full operati...

2025-07-29 15:44 3938

Ericsson announces completion of Aduna transaction

* Aduna now a 50:50 joint venture: 50 percent owned by Ericsson and 50 percent owned by twelve communications service providers (CSPs) * Aduna has been operational since its formation announcement on September 11, 2024 * Aduna ecosystem comprises CSP, major developer platform companies, glob...

2025-07-29 15:36 2266

Tigermed Completes Acquisition of Japanese CRO Micron

HANGZHOU, China and TOKYO, July 29, 2025 /PRNewswire/ -- Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Mic...

2025-07-29 13:37 4795

WAIC 2025: Shanghai Electric Debuts First Industrial Humanoid Robot "SUYUAN," Advancing Next-Gen Intelligent Manufacturing through Holistic Value Chain Layout

Boasting full-spectrum industrial capabilities from core technology development to integrated solutions,China's leading innovator drives the next-generation industrial revolution through a comprehensive industry chain strategy SHANGHAI, July 29, 2025 /PRNewswire/ -- Shanghai Electric

2025-07-29 13:14 4635

Introducing DXC Assure Risk Management: AI-Powered Claims Solution for Self-Insured Organizations

ASHBURN, Va., July 29, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced DXC Assure Risk Management, a next-generation solution that unites AI and human expertise to help self-insured organizations better manage employee ca...

2025-07-29 12:01 3744

Forrester To Recognize AIA Group As Its 2025 Customer-Obsessed Enterprise Award Winner At CX Summit APAC

SINGAPORE, July 29, 2025 /PRNewswire/ -- Forrester (Nasdaq: FORR) today announced AIA Group as the winner of its 2025 Customer-Obsessed Enterprise Award

2025-07-29 12:00 3595

Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ

SUZHOU, China, July 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of gastric cancer and ga...

2025-07-29 10:37 2521

Agoda Reveals First-Half 2025 Travel Insights: China, Malaysia, and South Korea Remain Top Visitors to Thailand

BANGKOK, July 29, 2025 /PRNewswire/ -- Digital travel platform Agoda reveals fresh insights into the Thai travel landscape for the first half of 2025. Based on booking data,China, Malaysia, and South Korea are once again the leading markets visitingThailand, followed by Japan and Singapore.

2025-07-29 10:05 3468

Agilent and Nanyang Technological University's NEWRI Sign Agreement to Enhance Water Contaminant Research in Singapore

SINGAPORE, July 29, 2025 /PRNewswire/ -- Agilent Technologies Inc.  (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with theNanyang Environment & Water Research Institute (NEWRI) , outlining their collaboration ...

2025-07-29 09:00 2918

CoAsia SEMI and Rebellions Join Forces to Jointly Develop Next-Generation AI Chiplet Based on REBEL

* Collaboration on Development and Supply of Next-Generation AI Chiplet and Server Software * Development and Verification by 2026; Large-Scale Mass Production Expected SEOUL, South Korea, July 29, 2025 /PRNewswire/ -- CoAsia SEMI (CEO DS, Shin), a system semiconductor design specialist sub...

2025-07-29 08:00 2498

CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series

Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All TOKYO, July 29, 2025 /PRNewswire/ -- CreateAI Holdings ("CreateAI" or the "Company") (OTC: TSPH), a leader in applied artificial intelligence technology, today announced the launch of the Studio Version of Animon....

2025-07-29 08:00 3398

SM nurtures next generation of entrepreneurs

PASAY CITY, Philippines, July 29, 2025 /PRNewswire/ -- Anchored on an inclusive supply chain network, the SM group's partner-MSMEs (micro, small, medium enterprises) have grown alongside the group. Home to the largest MSME community, SM is supporting over 100,000 MSMEs to date. Within the hund...

2025-07-29 06:09 2611

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced the appointment ofGreg Hughes to its Board of Directors effective July 25, 2025. A seasoned enterprise software executive, Hughes brin...

2025-07-29 04:53 2910

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + U.S. & EU reach trade...

2025-07-28 20:55 3298

Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug

- This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks the third approved indication of the drug inChina. - XPOVIO® as a monotherapy in patients with relap...

2025-07-28 18:49 3126
1 ... 182183184185186187188 ... 901